Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
A 66-year-old man has become the fourth person in the world to receive a genetically edited pig kidney transplant, performed ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
The fifth meeting of the Higher Committee for Integrated Industrial Partnership for Sustainable Economic Development held in ...
The 5th meeting of the Higher Committee commenced with the attendance of Industry Ministers from seven countries ...
It is closely associated with tumorigenesis and drug resistance, making it a potential target for oncology drug development. To date, no ROR1-targeting drugs have been marketed. BR111 utilizes ...
The fifth meeting of the Higher Committee for Integrated Industrial Partnership for Sustainable Economic Development ...
A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...
“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...